Atlas Trials

Exploratory Study of XL765 (SAR245409) or XL147 (SAR245408) in Subjects With Recurrent Glioblastoma Who Are Candidates for Surgical Resection

Clinical trial NCT01240460 · COMPLETED

Trial details

NCT number
NCT01240460
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
GlioblastomaAstrocytoma, Grade IV
Start date
2011-01-01
Primary completion
2012-06-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.